Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 3Completed 3Terminated 2Active not recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Neoplasms 2Cancer Patients 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

pembrolizumab 25Cyclophosphamide 20Nivolumab 13Doxorubicin 13Carboplatin 10Surveys and Questionnaires 9Paclitaxel 9Exercise 9atezolizumab 8Vincristine 8Rituximab 8Radiotherapy 8Prednisone 8Dexamethasone 8Bevacizumab 8venetoclax 7fludarabine 7Pemetrexed 7Fluorouracil 7Docetaxel 7Blood Specimen Collection 7lenvatinib 6dostarlimab 6cemiplimab 6budigalimab 6Oxaliplatin 6Cisplatin 6durvalumab 5Leucovorin 5Lenalidomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Neoplasms × Focus Groups × Clear all
NCT06549153 2026-03-09

ACT-Together (Acting on Cancer Testing-Together)

M.D. Anderson Cancer Center

Phase NA Active not recruiting
30 enrolled
Tumor-Agnostic

Neoplasms

NCT00832325 2026-03-03

Adolescent and Young Adult Cancer Survivors: Identity Development

Memorial Sloan Kettering Cancer Center

Active not recruiting
300 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡